The global disposable plastic blood bags size is expected to reach $530.0 million by 2030, growing at a CAGR of 6.1% from 2021 to 2030. Human blood and its components can be collected, stored, transported, and transfused using special bags. Hospitals, blood banks, government agencies, and non-government organizations (NGOs) that collect blood donations use these bags. As they are being used increasingly for transfusions, storage, and transportation, the demand for them is set to expand.
The market has a variety of products, including single, double, triple, and quadruple bags. Single disposable plastic blood bags dominated the market, with a revenue share of more than 70%, in 2021. Blood is collected and transfused using single bags made of high-quality polyethylene. The bags, which are attached to tubes, needles, and needle covers, are heat-resistant, which is why they are rather popular among hospitals, NGOs, blood banks, and other users.
Geographically, North America is projected to continue to rule the industry worldwide throughout the forecast timeframe. The demand for these products in the U.S. is set to grow as a result of the rising frequency of hematologic ailments and the healthcare sector's high need for blood collection and transfer bags. People with severe physical trauma as a result of auto accidents or any other accidental or non-accidental causes are at a constant risk of exsanguination, which creates the need for frequent transfusions.
Another important factor contributing to the disposable plastic blood bags market growth is the increase in the count of government measures to support blood donation campaigns. The ability to extract platelets and plasma, which are essential in the treatment of many diseases, from blood taken from diverse sources is expected to promote the expansion of the sector. This is itself credited to the rising need for blood transfusions for an array of diseases, such as thalassemia, anemia, certain cancers, liver diseases, and kidney diseases, sickle cell disease, and thrombocytopenia.
APAC is likely to witness a rapidly rising product demand in the approaching years due to a surge in the focus on the sterility, storage, transfusion, and transportation of blood and its components. The industry is expected to benefit from the rapid expansion of the healthcare sector, reflected in the construction of hospitals and clinics.
India and China will both experience notable growth in the market over this decade. This is credited to the expansion of medical device companies and healthcare facilities. The industry is predicted to expand further in the years to come as a result of the ongoing improvements and escalating need for better blood collecting technologies.
Furthermore, the Japanese industry is also expected to grow during the projection period due to the increasing number of hospitals and rising demand for these bags in blood banks. The disposable plastic blood bags market sales in Japan are set to increase as a result of the rising awareness of blood donation through publicity campaigns and government initiatives.
The key players in the market are SB-KAWASUMI LABORATORIES INC., Neomedic International SL, JMS Co. Ltd., AdvaCare Pharma, Macopharma, GenesisBPS, Nigale Sichuan Nigale Biomedical Co. Ltd., and Terumo Group.